Evidence map›Paper›PMID 40986168›Full record

ArticleMikrochimica acta2025

Correction: Multifunctional cerium nanolabels in electrochemical immunosensing with improved robustness and performance: determination of TIM-1 in colorectal cancer scenarios as a case study.

Andrea Cabrero-Martín, Sara Santiago, Verónica Serafín, María Pedrero, Ana Montero-Calle, José M Pingarrón, Rodrigo Barderas, Susana Campuzano

Abstract readPublished Erratum
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Andrea Cabrero-MartínDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID http://orcid.org/0009-0001-0785-1495
Sara SantiagoDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-1206-1455
Verónica SerafínDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0003-0034-8456
María PedreroDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0002-2047-396X
Ana Montero-CalleChronic Disease Programme, UFIEC, Institute of Health Carlos III, Majadahonda, 28220, Madrid, Spain.ORCID http://orcid.org/0000-0001-5141-0454
José M PingarrónDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID http://orcid.org/0000-0003-2271-1383
Rodrigo BarderasChronic Disease Programme, UFIEC, Institute of Health Carlos III, Majadahonda, 28220, Madrid, Spain. r.barderasm@isciii.es.ORCID http://orcid.org/0000-0003-3539-7469
Susana CampuzanoDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain. susanacr@quim.ucm.es.ORCID http://orcid.org/0000-0002-9928-6613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40986168
PMCPMC12457551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.